Atherosclerotic Lesions Prevented by MSCs

Stem cells were found to reduce plaque in patients with atherosclerosis.

According to new research from the National Yang-Ming University, mesenchymal stem cells [MSCs] hold the ability to limit atherosclerotic plaque formation, thereby preventing the onset of harmful endothelial lesions. The research team, led by Shih-Chieh Hung, transplanted MSCs into animal models with atherosclerosis and observed significant reduction in plaque formation. They also saw an increase in blood vessel dilation, which prevents further plaque development, indicating good endothelial health.

For patients predisposed to atherosclerosis, the accumulation of arterial plaque progresses rather quickly.  In these cases, the proteins secreted by MSCs during transplantation, in addition to a low fat diet, can help prevent deleterious lesions in the blood vessels, resulting in healthy blood vessels for all patients.

Mesenchymal stem cells have the unique capacity to differentiate into a multitude of different types of tissues – such as neurons, insulin producing pancreatic beta cells, bone, cartilage, and cardiomyocites amongst them.  To learn more about the value of preserving your own MSCs for use in future regenerative therapies and how to bank your own stem cells through a non-invasive and affordable method by recovering your dental pulp stem cells, visit StemSave or call 877-783-6728 (877-StemSave) today.

 

 

To view the full article, click here.

 

 

The Future of Regenerative Medicine is Now™.